WHO announces recommended viral composition for 2025 influenza vaccines

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2025 influenza season in the southern hemisphere.

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

Plus, news about Xencor, Bambusa Therapeutics, Grin Therapeutics and Vaxcyte: Immunovant reports Phase 2a Graves’ disease data: Patients taking batoclimab for 12 weeks saw a

September 10, 2024

Evening chronotype linked to unhealthy lifestyles and increased diabetes risk, reveals cohort study

September 12, 2023

Study reveals how do people react to anti-vaxxer deaths

When people who publicly reject COVID-19 vaccines later die from the disease, observers have complex reactions to their fates, a new study suggests.

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.